Definition:Mortality improvement factor
📈 Mortality improvement factor is an actuarial adjustment applied to base mortality table rates to account for the expected decline in death rates over time, reflecting advances in healthcare, lifestyle changes, and broader public health trends. Life insurers, annuity providers, and pension funds rely on these factors to ensure that their long-duration obligations are priced and reserved in line with the reality that people, on average, are living longer than historical tables would suggest.
🔧 Actuaries derive mortality improvement factors from longitudinal analysis of population-level death data — typically national vital statistics — and from the insurer's own mortality experience. A common approach assigns an annual percentage reduction to each age-gender cell in the base mortality table. For example, if the base table projects a death rate of 5 per 1,000 for 65-year-old males, and a 1.5% annual improvement factor is applied, the projected rate one year forward would drop to approximately 4.925 per 1,000. Organizations such as the Society of Actuaries publish widely used improvement scales — Scale MP and its successors — that insurers may adopt directly or calibrate to their own data. The choice of improvement factor has a pronounced impact on reserve calculations and premium levels, especially for products with long durations like whole life, long-term care, and payout annuities.
🎯 Getting mortality improvement right is a balancing act with real financial stakes. Overestimating improvement leads to annuity reserves that are too high and life insurance premiums that are too low, while underestimating improvement can leave annuity writers exposed to longevity risk — the danger that policyholders outlive their projected lifespans and draw benefits far longer than anticipated. The assumption is not purely academic; events such as the stalling of life-expectancy gains in certain countries, the opioid epidemic, and COVID-19 have forced actuaries to reconsider whether historical improvement trends will continue unabated. Regulators increasingly require insurers to disclose and justify their mortality improvement assumptions, and reinsurers stress-test these factors when evaluating the tail risk embedded in life and annuity portfolios.
Related concepts: